Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases

Abstract

ObjectiveTo perform a systematic literature review (SLR) on different outcomes of remote care compared with face-to-face (F2F) care, its implementation into clinical practice and to identify drivers and barriers in order to inform a task force formulating the EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases (RMDs).MethodsA search strategy was developed and run in Medline (PubMed), Embase and Cochrane Library. Two reviewers independently performed standardised data extraction, synthesis and risk of bias (RoB) assessment.ResultsA total of 2240 references were identified. Forty-seven of them fulfilled the inclusion criteria. Remote monitoring (n=35) was most frequently studied, with telephone/video calls being the most common mode of delivery (n=30). Of the 34 studies investigating outcomes of remote care, the majority addressed efficacy and user perception; 34% and 21% of them, respectively, reported a superiority of remote care as compared with F2F care. Time and cost savings were reported as major benefits, technical aspects as major drawback in the 13 studies that investigated drivers and barriers of remote care. No study addressed remote care implementation. The main limitation of the studies identified was the heterogeneity of outcomes and methods, as well as a substantial RoB (50% of studies with high RoB).ConclusionsRemote care leads to similar or better results compared with F2F treatment concerning efficacy, safety, adherence and user perception outcomes, with the limitation of heterogeneity and considerable RoB of the available studies.

Virtual Tools to Enable Management of Knee Osteoarthritis

“…Compared to videoconferencing, more research has focused on telephonedelivered interventions for people with knee OA [13•, 14, 15••, 16, 17,35]. Numerous RCTs have shown that telephone-delivered exercise can benefit people with knee OA.…”

Future challenges in rheumatology – is telemedicine the solution?

“…Results from a recent EULAR guideline on remote care show 10,11 that the vast majority of studies have been conducted within non-inflammatory RMDs, with osteoarthritis (OA) being the disease where most telehealth interventions have been developed. Within inflammatory RMDs, most interventions have been developed for patients with rheumatoid arthritis (RA).…”

Reply: Who can get it right for polymyalgia rheumatica?

“…We have recently published guidance on the use of telemedicine in rheumatology (7). During the systemic literature review for that topic, we did not find any polymyalgia rheumatica specific study (8). Telemedicine would certainly facilitate pre-diagnostic processes and in some instances ruling out a diagnosis of polymyalgia rheumatica, but a diagnosis should always be established in a face-toface visit after clinical examination (7).…”